132 related articles for article (PubMed ID: 12120251)
1. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs.
Yamauchi J; Takeda K; Shibuya K; Sunamura M; Matsuno S
Pancreatology; 2001; 1(6):662-7. PubMed ID: 12120251
[TBL] [Abstract][Full Text] [Related]
2. [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction].
Kakugawa Y; Takeda K; Sunamura M; Kawaguchi S; Kobari M; Matsuno S
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1444-50. PubMed ID: 2214268
[TBL] [Abstract][Full Text] [Related]
3. Site-specific therapeutic effects of protease inhibitors: effect of route of administration in experimental pancreatitis.
Keck T
Pancreatology; 2001; 1(6):656-61. PubMed ID: 12120250
[TBL] [Abstract][Full Text] [Related]
4. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis.
Mikami Y; Takeda K; Matsuda K; Qiu-Feng H; Fukuyama S; Egawa S; Sunamura M; Matsuno S
Pancreas; 2005 Apr; 30(3):248-53. PubMed ID: 15782103
[TBL] [Abstract][Full Text] [Related]
5. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Keck T; Balcom JH; Antoniu BA; Lewandrowski K; Warshaw AL; Fernández-del Castillo CF
Surgery; 2001 Aug; 130(2):175-81. PubMed ID: 11490346
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
7. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial.
Hirota M; Shimosegawa T; Kitamura K; Takeda K; Takeyama Y; Mayumi T; Ito T; Takenaka M; Iwasaki E; Sawano H; Ishida E; Miura S; Masamune A; Nakai Y; Mitoro A; Maguchi H; Kimura K; Sanuki T; Ito T; Haradome H; Kozaka K; Gabata T; Kataoka K; Hirota M; Isaji S; Nakamura R; Yamagiwa K; Kayaba C; Ikeda K
J Gastroenterol; 2020 Mar; 55(3):342-352. PubMed ID: 31758329
[TBL] [Abstract][Full Text] [Related]
8. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
9. Role of early continuous regional arterial infusion of protease inhibitor and antibiotic in nonsurgical treatment of acute necrotizing pancreatitis.
Takeda K; Sunamura M; Shibuya K; Kobari M; Matsuno S
Digestion; 1999; 60 Suppl 1():9-13. PubMed ID: 10026424
[TBL] [Abstract][Full Text] [Related]
10. The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis.
Satoh H; Harada M; Tashiro S; Shiroya T; Imawaka H; Machii K
J Med Invest; 2004 Aug; 51(3-4):186-93. PubMed ID: 15460905
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
12. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
[TBL] [Abstract][Full Text] [Related]
13. [Continuous regional arterial infusion of protease inhibitor and antibiotic for severe acute pancreatitis].
Takeda K
Nihon Rinsho; 2004 Nov; 62(11):2101-7. PubMed ID: 15552895
[TBL] [Abstract][Full Text] [Related]
14. Antiproteases in the treatment of acute necrotizing pancreatitis: continuous regional arterial infusion.
Takeda K
JOP; 2007 Jul; 8(4 Suppl):526-32. PubMed ID: 17625310
[TBL] [Abstract][Full Text] [Related]
15. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175).
Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
Thromb Res; 1992 Jan; 65(2):229-39. PubMed ID: 1579898
[TBL] [Abstract][Full Text] [Related]
16. Effect of FUT-175 (nafamstat mesilate) on platelets in canine acute experimental pancreatitis.
Gabryelewicz A; Prokopowicz J; Bodzenta A; Bielecki W; Rydzewska G
Digestion; 1988; 40(1):19-24. PubMed ID: 3234615
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
18. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.
Takeda K; Matsuno S; Sunamura M; Kakugawa Y
Am J Surg; 1996 Apr; 171(4):394-8. PubMed ID: 8604829
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation].
Tsukagoshi S
Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
